Buffington Mohr McNeal’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,680
| Closed | -$299K | – | 112 |
|
|
2024
Q4 | $299K | Hold |
1,680
| – | – | 0.05% | 115 |
|
|
2024
Q3 | $332K | Hold |
1,680
| – | – | 0.05% | 109 |
|
|
2024
Q2 | $288K | Buy |
1,680
+35
| +2% | +$6K | 0.05% | 109 |
|
|
2024
Q1 | $300K | Hold |
1,645
| – | – | 0.05% | 111 |
|
|
2023
Q4 | $255K | Hold |
1,645
| – | – | 0.05% | 117 |
|
|
2023
Q3 | $245K | Sell |
1,645
-263
| -14% | -$39.2K | 0.06% | 113 |
|
|
2023
Q2 | $257K | Buy |
+1,908
| New | +$257K | 0.06% | 112 |
|
|
2019
Q2 | – | Sell |
-631
| Closed | -$51K | – | 118 |
|
|
2019
Q1 | $51K | Buy |
+631
| New | +$51K | 0.02% | 185 |
|
|
2017
Q1 | – | Sell |
-1,700
| Closed | -$106K | – | 111 |
|
|
2016
Q4 | $106K | Buy |
+1,700
| New | +$106K | 0.04% | 166 |
|
|
2016
Q3 | – | Sell |
-5,200
| Closed | -$322K | – | 157 |
|
|
2016
Q2 | $322K | Sell |
5,200
-2,150
| -29% | -$133K | 0.14% | 101 |
|
|
2016
Q1 | $419K | Buy |
7,350
+1,550
| +27% | +$88.4K | 0.18% | 93 |
|
|
2015
Q4 | $344K | Buy |
+5,800
| New | +$344K | 0.18% | 76 |
|